Education
About Us
Working with TipRanks
Follow Us
ELEVAI Labs Inc. (ELAB)
NASDAQ:ELAB
ELAB Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.26 - $1,064.00
Previous CloseN/A
Volume180.10K
Average Volume (3M)786.98K
Market Cap
$1.84M
Enterprise Value-$4.48M
Total Cash (Recent Filing)$1.15M
Total Debt (Recent Filing)$283.22K
Price to Earnings (P/E)―
Beta0.41
Next Earnings
May 14, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-409.35
Shares Outstanding707,076
10 Day Avg. Volume1,539,315
30 Day Avg. Volume786,980
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.63
Price to Cash Flow (P/CF)-1.90
P/FCF Ratio0.00
Enterprise Value/Market Cap-2.44
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.97
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
ELEVAI Labs Inc. News
PremiumCompany Announcements
PMGC Holdings Announces Acquisition of IT Packaging Firm---
Ownership Overview
25.70%
Insiders
―
Mutual Funds
0.82% Other Institutional Investors
74.30% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
ELAB FAQ
What was ELEVAI Labs Inc.’s price range in the past 12 months?
ELEVAI Labs Inc. lowest stock price was $2.26 and its highest was $1064.00 in the past 12 months.
What is ELEVAI Labs Inc.’s market cap?
ELEVAI Labs Inc.’s market cap is $1.84M.
When is ELEVAI Labs Inc.’s upcoming earnings report date?
ELEVAI Labs Inc.’s upcoming earnings report date is May 14, 2025 which is in 22 days.
How were ELEVAI Labs Inc.’s earnings last quarter?
Currently, no data Available
Is ELEVAI Labs Inc. overvalued?
According to Wall Street analysts ELEVAI Labs Inc.’s price is currently Overvalued.
Does ELEVAI Labs Inc. pay dividends?
ELEVAI Labs Inc. does not currently pay dividends.
What is ELEVAI Labs Inc.’s EPS estimate?
ELEVAI Labs Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ELEVAI Labs Inc. have?
ELEVAI Labs Inc. has 707,076 shares outstanding.
What happened to ELEVAI Labs Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of ELEVAI Labs Inc.?
Currently, no hedge funds are holding shares in ELAB
---
Company Description
ELEVAI Labs Inc.
Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.
---
Technical Analysis
TNF Pharmaceuticals
―
Scinai Immunotherapeutics
―
Entero Therapeutics
―
Protagenic Therapeutics
―
ZyVersa Therapeutics
―
---